Arcam AB, the Swedish manufacturer of electron beam Additive Manufacturing systems, has announced it has acquired DiSanto Technology (DiSanto), a strategic partner to Arcam since early 2013.
DiSanto is a fully equipped and certified production facility for the manufacture of finished orthopaedic implants located in Shelton, Connecticut, USA, with approximately 100 employees. In the last 12 months DiSanto generated approximately $12M in revenue and an EBIT of $0.6M. The total purchase price amounts to $15.8M paid in cash and through the execution of Arcam stock options issued to the sellers in February 2013.
The acquired business will become a subsidiary of Arcam and continue operating with the existing management team.
“Through this acquisition Arcam’s offering will cover the entire supply chain for our customers: Metal powders through AP&C, acquired earlier this year, EBM systems and services through Arcam AB and finished products through DiSanto. The acquisition is thus in line with our growth strategy, it complements our technology and product portfolio, and it is immediately accretive. We are very pleased to welcome the skilled DiSanto team to the Arcam group,” stated Magnus René, CEO of Arcam.
“With this deal we will be part of the leading company in 3D-printing in metals. This will enable us to help customers in rapidly developing product applications and to commercially produce products for them with Arcam’s cost-efficient, regulatory-cleared Additive Manufacturing technology. Being part of a larger group will also help in accelerating growth to better serve the growing implant market,” added Ronald F Dunn, President of DiSanto Technology.